Stocks in play: CareRx Corporation
Welcomes the decision by the Ontario Government to pause the previously scheduled changes to long-term care pharmacy funding that were scheduled to go into effect on April 1. shares T.CRRX are trading down $0.06 at $1.99.
Read:
Global Efforts Intensify to Address Surging Young Adult Colorectal and Anal Cancer Rates
Harnessing AI's $4.4 Trillion Potential Reshapes the Tech Industry Landscape
Critical Push for US Domestic Nickel Needed to Halt Total Reliance on Questionable Foreign Imports
How Argentina’s New Power Moves Look to Lure Even More Lithium Interest Towards the Country
How Recent Biotech Breakthroughs Are Changing the Fight Against Breast Cancer